Table 5. MCF-7 viability and inhibition% data following TMZ treatment (48 hr exposure, n=9)

From

Dual Epigenetic Impacts of Temozolomide on the Sensitivity of ER-positive and ER-negative Breast Cancer and Glioma Cells

Viacheslav S, Jorge S., Perez C., Prajapati J., Diaz A.J., Wang T.

American Journal of Medicine Studies. 2026, 11(1), 8-15 doi:10.12691/ajms-11-1-2